ARCHIVES

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

Pain Relievers Protect Against Breast Cancer

April 25, 2003

With workload Up, Oncology Division To Add More Staff

August 2, 1996

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

December 12, 2003

Construction Gets Extra $1 Million, Six Grants Okayed

May 29, 1981